Arcutis Biotherapeutics (ARQT) EPS (Basic) (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly EPS (Basic) of -$87.31 for Q1 2026, down 43812.28% year-over-year from N/an in Q1 2025, and down 64069.48% quarter-over-quarter from $0.14 in Q4 2025.
Arcutis Biotherapeutics (ARQT) EPS (Basic) (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$87.31 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 43812.28% year-over-year to -$87.31; the TTM figure through Mar 2026 stood at -$18.59 (down 1706.34% YoY), while the FY2025 annual figure was -$0.13, up 89.02% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$87.31, down from $0.14 in the prior quarter.
- The five-year high for EPS (Basic) was $0.14 in Q4 2025, with the low at -$87.31 in Q1 2026.
- The 5-year median for EPS (Basic) is -$0.73 (2023), against an average of -$5.8.
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) surged 253.03% in 2025, then plunged 43812.28% in 2026.
- Arcutis Biotherapeutics' EPS (Basic) stood at -$1.31 in 2022, then rose by 26.92% to -$0.96 in 2023, then surged by 90.67% to -$0.09 in 2024, then soared by 253.03% to $0.14 in 2025, then slumped by 64069.48% to -$87.31 in 2026.
- Business Quant data shows ARQT's EPS (Basic) at -$87.31 in Q1 2026, $0.14 in Q4 2025, and $0.06 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11 |
| Mar 31, 2026 | -87.31 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | -0.13 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.33 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.32 |
| Dec 31, 2023 | -0.96 |
| Sep 30, 2023 | -0.73 |
| Jun 30, 2023 | -1.16 |
| Mar 31, 2023 | -1.31 |
| Dec 31, 2022 | -1.31 |
| Sep 30, 2022 | -1.89 |
| Jun 30, 2022 | -1.32 |
| Mar 31, 2022 | -1.29 |
| Dec 31, 2021 | -1.45 |
| Sep 30, 2021 | -1.14 |